Philadelphias transit agency has sued Gilead Sciences Inc accusing the company of pricegouging on the sale of its perpill hepatitis C drug Sovaldi the latest salvo in a battle between healthcare payers and the pharmaceutical industry over prices The Southeastern Pennsylvania Transportation Authority or Septa filed the lawsuit on Tuesday in US District Court for the Eastern District of Pennsylvania The suit seeks classaction status subject to certification by a judge on behalf of any person or entity
  